In good news for diabetics, new drug to be 60% cheaper
In good news for diabetics, new drug to be 60% cheaper Diabetics in the country have something to cheer about. A completely new drug in the SGLT2 Inhibitor (sodium glucose cotransporter-2) family is being introduced here for the first time globally, which promises to disrupt the anti-diabetes market by lowering cost of therapy by nearly